“Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A”: In April 2011, Critical Reviews in Toxicology released a review on BPA conducted by the Advisory Committee, which concluded, “BPA exposure represents no noteworthy risk to the health of the human population, including newborns and babies.”
Furthermore, it found, “To date, more than 5,000 studies on BPA have been published. It is obvious that this should be enough information to resolve the controversy, but nevertheless this has not yet been achieved and those not directly involved in BPA research are usually puzzled by the never-ending and sometimes emotional debate.” After reviewing all available evidence and controversial arguments, the Committee concluded that the “current Tolerable Daily Intake (TDI) level for BPA is adequately justified.” In its specific evaluation of studies reporting that low doses of BPA cause adverse health effects in laboratory animals, the Committee found that these studies “failed to meet minimal quality criteria for experimental design and statistical analysis” and that their results were inconsistent with more robust studies on similar endpoints. A full report can be found here.